Showing results (401-410 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|January 22, 2025
Cardiovascular health in breast cancer patients: insight on BRCA1/2 mutations impactPanagiotis Mallios, Mehdi Dehghan Manshadi, Laila Hubbert, et al.Cardio-Oncology (London, England)|January 4, 2025
Cardiorespiratory fitness, cardiac morphology and function, and cardiovascular risk factors in long-term breast cancer survivors compared with non-cancer controlsMali Sæter, Sara Hassing Johansen, Kristin Valborg Reinertsen, et al.Cardio-Oncology (London, England)|March 5, 2025
Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapyAya F Ozaki, Michael Sayer, Hirofumi Hamano, et al.Cardio-Oncology (London, England)|September 7, 2024
Cardiovascular and venous thromboembolism risks in cancer patients treated with immune checkpoint inhibitors compared to non-users- a multi-center retrospective studyJian-Rong Peng, Jason Chia-Hsun Hsieh, Chih-Hao Chang, et al.Cardio-Oncology (London, England)|September 5, 2024
Hypothesis paper: GDF15 demonstrated promising potential in Cancer diagnosis and correlated with cardiac biomarkersXiaohe Hao, Zhenyu Zhang, Jing Kong, et al.Cardio-Oncology (London, England)|August 26, 2024
Cancer therapy-related cardiac dysfunction after radiation therapy for breast cancer: results from the BACCARAT cohort studyM K Honaryar, M Locquet, R Allodji, et al.Cardio-Oncology (London, England)|August 22, 2024
Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditisJieli Tong, Nikolaos Vogiatzakis, Maria Sol Andres, et al.Cardio-Oncology (London, England)|November 8, 2024
Increasing clinicians' suspicion of ATTR amyloidosis using a retrospective algorithmJessica Ammon, John Alexander, Woodson Petit-Frere, et al.Cardio-Oncology (London, England)|July 15, 2024
Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk scoreFiona Fernando, Maria Sol Andres, Simone Claudiani, et al.Cardio-Oncology (London, England)|August 7, 2024
Crosslink between atrial fibrillation and cancer: a therapeutic conundrumErmanno Nardi, Ciro Santoro, Maria Prastaro, et al.Pageof 45